Octagon Capital Advisors LP
Q4 2025 13F Holdings
- Locationnew york, NY
- Num holdings
27
- Value ($000)
$823,679
- Date Filed02/17/2026
- Form type13F-HR
- CIK0001839435
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ABIVAX SA | SPONSORED ADS | 00370M103 | $101.95M | 12 % | 756,000 | ||
DIANTHUS THERAPEUTICS INC | COM | 252828108 | $99.59M | 12 % | 2,416,667 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | $83.47M | 10 % | 2,350,000 | ||
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | $48.73M | 6 % | 8,859,911 | ||
GOSSAMER BIO INC | COM | 38341P102 | $43.14M | 5 % | 13,915,371 | ||
KYMERA THERAPEUTICS INC | COM | 501575104 | $41.63M | 5 % | 535,000 | ||
ARRIVENT BIOPHARMA INC | COM | 04272N102 | $39.66M | 5 % | 1,971,054 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | $35.24M | 4 % | 2,815,000 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | $31.85M | 4 % | 2,623,600 | ||
MIND MEDICINE MINDMED INC | COM NEW | 60255C885 | $29.86M | 4 % | 2,230,000 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100